YOKNEAM, Israel, July 25, 2012 /PRNewswire/ -- Syneron
Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device
company, today announced that it will release second quarter 2012
financial results before the market opens on Wednesday, August 15, 2012. The earnings release
will be available on Syneron's website at www.syneron.com.
(Logo:
http://photos.prnewswire.com/prnh/20120528/535447 )
Syneron management will host a conference call and a live
webcast at 8:30 a.m. (ET) on the same
day. A question & answer session will follow management's
discussion of events in the second quarter 2012.
Investors and analysts may participate in the conference call
using the following dial-in numbers:
US (toll free): (877) 844-6886
International: (970) 315-0315
The conference passcode for both is 13010078.
Investors and other interested parties can also access a live
webcast of the conference call through the Investor Overview page
on Syneron's website at www.syneron.com. Please log-in at least 10
minutes prior to the conference call in order to download the
applicable audio software. Following the conclusion of the call, a
replay of the webcast will be available within 24 hours on the
Company's website.
About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global
aesthetic device company with a comprehensive product portfolio and
a global distribution footprint. The Company's technology enables
physicians to provide advanced solutions for a broad range of
medical-aesthetic applications including body contouring, hair
removal, wrinkle reduction, rejuvenation of the skin's appearance
through the treatment of superficial benign vascular and pigmented
lesions, and the treatment of acne, leg veins and cellulite. The
Company sells its products under two distinct brands, Syneron and
Candela. Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and
manufacturing operations in the US. The Company markets and
services and supports its products in 90 countries. It has offices
in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan,
and Hong Kong and distributors
worldwide.
SOURCE Syneron Medical Ltd.